Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,155,695
-$415,914 QoQ
Shares Held
47,994
-14.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#1,243
of 2,821 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRED AVON FAMILY WEALTH, LLC holds $19,035,397 across 10 Drug Manufacturers - General names. PFE ranks #5 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,826 | $6,559,029 | |
| 2 | LLY |
ELI LILLY & Co
|
3,283 | $3,937,729 | |
| 3 | ABBV |
AbbVie Inc.
|
10,584 | $2,663,357 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
22,926 | $1,320,996 | |
| 5 | PFE |
Pfizer Inc
This page
|
47,994 | $1,155,695 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,159 | $904,468 | |
| 7 | GSK |
GSK plc
|
16,632 | $871,849 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,618 | $593,413 |
All Filings in PFE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,155,695 | 47,994 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,571,609 | 55,969 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,259,118 | 50,567 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,420,102 | 55,734 | Shares | Sole | 2025-10-29 | |
| No filing history on record for this holder in this stock. | ||||||